

Jeff Cardenas
CEO of Apptronik, a company specializing in humanoid robots. Focuses on creating general-purpose robots for various industries.
Top 5 podcasts with Jeff Cardenas
Ranked by the Snipd community

165 snips
Jul 1, 2025 • 1h 27min
The Grammarly–Superhuman Megadeal, plus TWiST 500 chats with LabelBox and Apptronik’s founders | E2146
Shishir Mehrotra, CEO of Grammarly, and Rahul Vohra, founder of Superhuman, dive into their exciting merger, analyzing how this combination aims to revolutionize email and productivity tools with AI. They discuss leveraging Grammarly's vast user base to enhance user experience and make communication more efficient. Additionally, Manu Sharma of Labelbox and Jeff Cardenas of Apptronik share insights on the future of AI-driven tools and humanoid robots, emphasizing their roles in various industries and the importance of data labeling in AI development.

16 snips
Dec 26, 2025 • 33min
Encore: This CEO Says Humanoid Robots Are The "Space Race" of Our Time
Who will take care of you in old age? Jeff Cardenas, the CEO and co-founder of Apptronik, says the answer is robots. The startup founder set out to build a smart, dexterous robot after watching his grandfathers grow old and dependent in their later years. Beyond healthcare, Cardenas sees robots as essential to U.S. economic growth and national security with applications across industries. Even with the latest advances in artificial intelligence and hardware, what will it take for humanoid robots to make the leap from science fiction to reality? On the latest episode of the Bold Names podcast, Cardenas tells WSJ’s Christopher Mims and Tim Higgins why Apptronik is betting it will create the home robot helper that everyone will want.
To watch the video version of this episode, visit our WSJ Podcasts YouTube channel or the video page of WSJ.com.
Check Out Past Episodes:
Condoleezza Rice on Beating China in the Tech Race: 'Run Hard and Run Fast'
Reid Hoffman Says AI Isn’t an ‘Arms Race,’ but America Needs to Win
Why This Investor Says the AI Boom Isn’t the Next Dot-Com Crash
How the U.S. Stacks Up to China’s ‘Engineering State’
Let us know what you think of the show. Email us at BoldNames@wsj.com.
Sign up for the WSJ's free Technology newsletter.
Read Christopher Mims’s Keywords column.Read Tim Higgins’s column.
Learn more about your ad choices. Visit megaphone.fm/adchoices

16 snips
Sep 26, 2025 • 32min
The Google-Backed Startup Taking on Elon Musk in Humanoid Robotics
Jeff Cardenas, Co-founder and CEO of Apptronik, shares his vision of humanoid robots as our future caregivers, inspired by his aging grandfathers. He outlines a three-stage roadmap for robot deployment, from industries to homes by 2035. Cardenas emphasizes the importance of owning actuators for enhanced robot dexterity and discusses Apptronik's collaborations with Google and DeepMind AI. He also explains how robots can become affordable, costing under $50,000, and argues that robotics will revolutionize productivity and national security in the U.S.
4 snips
Aug 23, 2023 • 1h 19min
Shaping the Future: Apptronik CEO Jeff Cardenas and the Apollo Humanoid
Apptronik CEO Jeff Cardenas discusses the development of legged robotics and the launch of the company's first commercial humanoid robot, Apollo. They also explore the market potential and demand for humanoid robots in the logistics industry, highlighting the challenges and opportunities. The discussion emphasizes the performance, affordability, and unique design of the Apollo humanoid robot.

Mar 28, 2025 • 42min
Will your humanoid robot compliment you? And the end of 23andMe?
Jeff Cardenas, CEO and co-founder of Apptronik, shares insights on the future of humanoid robots, emphasizing their design and potential roles in elder care and addressing labor shortages. The conversation dives into the intriguing notion of robots having personality traits and the emotional impact of their design on human interaction. Cardenas and the host also candidly discuss the downfall of 23andMe, exploring how a once-prominent biotech startup faced bankruptcy amid shifting health tech landscapes.


